Utah Medical Products, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $109.2M | $65.9M |
| Jun 2022 | — | $107.5M | $66.2M |
| Sep 2022 | — | $108.2M | $69.5M |
| Dec 2022 | $0 | $114.3M | $75.1M |
| Mar 2023 | — | $118.0M | $80.9M |
| Jun 2023 | — | $121.8M | $84.6M |
| Sep 2023 | — | $123.7M | $88.2M |
| Dec 2023 | $0 | $128.3M | $92.9M |
| Mar 2024 | — | $127.7M | $93.8M |
| Jun 2024 | — | $124.1M | $89.2M |
| Sep 2024 | — | $124.2M | $88.5M |
| Dec 2024 | $0 | $117.4M | $83.0M |
| Mar 2025 | $269.0K | $117.0M | $83.3M |
| Jun 2025 | — | $117.5M | $82.2M |
| Sep 2025 | — | $118.3M | $84.3M |
| Dec 2025 | $0 | $119.3M | $85.8M |
| Mar 2026 | $210.0K | $120.4M | $87.4M |
| Jun 2026 | $195.0K | $122.0M | $87.5M |